Although still in Phase I, Wave Life Sciences’ injectable RNA weight loss treatment achieved results that impressed analysts, ...

The World Health Organization is now recommending GLP-1 drugs as a tool to manage obesity in adults. The guidance, which says ...

Ascletis Pharma, Inc. ( ($HK:1672) ) has issued an announcement. Ascletis Pharma Inc. announced positive results from its 13-week Phase II study ...

The World Health Organization conditionally recommended GLP-1 drugs for obesity. A physician breaks down what you need to ...

Amid soaring global demand for glucagon-like peptide-1 (GLP-1) medications and widespread concerns about affordability and access, the World Health Organization (WHO) released its global comprehensive ...

The recommended use of GLP-1 therapies, including tirzepatide (Zepbound), semaglutide (Wegovy), and liraglutide (Saxenda), for adults with obesity is "grounded in the recognition of obesity as a ...

As the World Health Organization conditionally recommends the use of GLP-1 medications to treat obesity, a Halifax-based ...

Obesity is one of the most common and complex chronic diseases clinicians encounter in practice. Yet it is still often ...

This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity ...

Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor ...

The weight loss medications can be part of a long-term treatment strategy for adults, according to new World Health ...